vancomycin has been researched along with Virus Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cuervas-Mons, V; Dámaso, D; Losada, I; Millán, I | 1 |
Giamarellou, H | 1 |
Klastersky, J | 1 |
Block, JB; Cusack, N; Fortner, CL; Greene, WH; Schimpff, SC; Wiernik, PH; Young, VM | 1 |
2 review(s) available for vancomycin and Virus Diseases
Article | Year |
---|---|
Empiric therapy for infections in the febrile, neutropenic, compromised host.
Topics: Algorithms; Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Immunocompromised Host; Lactams; Mycoses; Neutropenia; Quinolones; Sulfamethoxazole; Time Factors; Trimethoprim; Vancomycin; Virus Diseases | 1995 |
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
1 trial(s) available for vancomycin and Virus Diseases
Article | Year |
---|---|
Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Air Conditioning; Air Microbiology; Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Environment, Controlled; Female; Gentamicins; Hospital Units; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Male; Middle Aged; Nystatin; Patient Isolators; Remission, Spontaneous; Urinary Tract Infections; Vancomycin; Ventilation; Virus Diseases | 1975 |
1 other study(ies) available for vancomycin and Virus Diseases
Article | Year |
---|---|
[Early infection in liver transplant recipients: incidence, severity, risk factors and antibiotic sensitivity of bacterial isolates].
Topics: 4-Quinolones; Adult; Anti-Infective Agents; Bacterial Infections; Disease Susceptibility; Drug Resistance; Female; Graft Rejection; Humans; Immunocompromised Host; Immunosuppression Therapy; Incidence; Infection Control; Infections; Liver Transplantation; Male; Middle Aged; Mycoses; Postoperative Complications; Postoperative Period; Premedication; Preoperative Care; Retrospective Studies; Risk Factors; Spain; Teicoplanin; Vancomycin; Virus Diseases | 2002 |